D. Olivieri (Parma, Italy), P. Camus (Dijon, France)
Prevalance of pulmonary hypertension in chronic myeloproliferative diseases E. Kiyan, G. Okumus, G. Kuran, B. Pamukcu, H. Göksoy, A. Kiyan, S. Yavuz, Z. Bugra, O. Arseven (Istanbul, Bolu, Turkey)
| |
Adipokines and bone loss at the terminal stage of chronic respiratory failure E. Kochetrova, L. Ugay, K. Burya, R. Kessler (Vladivostok, Russian Federation; Strasbourg, France)
| |
Bronchoalveolar interleukin-1 beta: A marker of bacterial burden in children with community-acquired pneumonia (CAP) D. Dmytriiev, K. Dmytriieva, K. Dmytriiev, O. Katilov, A. Staradub (Vinnitsa, Ukraine)
| |
Features of lung damage in adult patients with severe influenza A (H1N1) O. Titova, D. Larin, V. Volchkov (Saint-Petersburg, Russian Federation)
| |
Specialist palliative care is more than drugs – A retrospective study of ILD patients S. Bajwah, I. J. Higginson, J. Ross, A. U. Wells, S. S. Birring, A. Patel, J. Riley (London, United Kingdom)
| |
Community-acquired pneumonia in pediatric patients with connective tissue disorders: Manifestations and clinical course Z. Nesterenko, O. Ivanina (Lugansk, Ukraine)
| |
Clinical features of a new hypersensitivity pneumonitis: Salami brusher‘s disease L. Balzarini, C. Mancini, P. Mouzakiti, M. Marvisi (Cremona, Italy)
| |